title: Oxidized-LDL immunization for the treatment of atherosclerosis: how far are we?
authors.affiliation: Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; 1st Cardiology Department, Athens University Medical School, Hippokration Hospital, Greece. Electronic address: drnpapageorgiou@yahoo.com.
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Papageorgiou
authors.affiliation: 1st Cardiology Department, Athens University Medical School, Hippokration Hospital, Greece.
authors.forename: Dimitris
authors.initials: D
authors.lastname: Tousoulis
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D050197:Atherosclerosis / Q000276:immunology / Q000628:therapy; D006801:Humans; D007114:Immunization / Q000379:methods*; D007155:Immunologic Factors / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000276:immunology / Q000494:pharmacology; D010084:Oxidation-Reduction
chemical_list: D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein